Corporate Market Update – 22 October 2026
The Chinese equity market closed in a period of relative calm, with the Doctorglasses Chain (300622.SZ) remaining unchanged for the 24‑hour window that ended at 02:16 AM Central European Time. While the stock price held steady at roughly CNY 14.66, the underlying market dynamics reveal a broader trend of muted activity and modest valuation pressures.
Doctorglasses Chain: Key Metrics
- Current Share Price: CNY 14.66
- Total Shares Outstanding: 319 million
- Market Capitalisation: CNY 4.7 billion
- Average Daily Volume (Last 24 h): CNY 150.4 million
- Price Change Since Last Month‑End: –5.48 %
- 200‑Day Simple Moving Average: CNY 15.01
- 52‑Week High/Low: CNY 27.78 (14 Jan 2026) / CNY 13.09 (14 Jul 2026)
The flat 0 % movement in the last 24 hours is contrasted by the decline that has already occurred over the previous month. Despite the lack of intraday volatility, the trading volume of CNY 150.4 million indicates that a significant amount of capital is still circulating for this stock, suggesting that investors are maintaining a long‑term view rather than engaging in speculative trades.
Peer Performance Snapshot
| Stock | Symbol | Price | Market Cap | P/E Ratio | 24‑Hour Move |
|---|---|---|---|---|---|
| Zhejiang Goldensea Hi‑tech | 603311.SS | CNY 23.6 | CNY 5.6 bn | 89.45 | 0 % |
| Anhui Zhongdianxinlong Sci | 002298.SZ | CNY 7.65 | CNY 5.6 bn | — | 0 % |
| Wuhan Keqian Biology Lt | 688526.SS | CNY 12.02 | CNY 5.6 bn | 18.15 | 0 % |
| Dongfeng Electronic Tech | 600081.SS | CNY 10.02 | CNY 5.6 bn | 85.92 | 0 % |
| Guangzhou Hengyun Enterpr | 000531.SZ | CNY 5.33 | CNY 5.6 bn | 16.79 | 0 % |
All five peer stocks displayed a 0 % change in the same 24‑hour period, underscoring a broader trend of equilibrium across sectors. While the price‑to‑earnings ratios of some peers (e.g., Zhejiang Goldensea Hi‑tech and Dongfeng Electronic Tech) sit at high levels, Wuhan Keqian Biology Lt and Guangzhou Hengyun Enterpr maintain more modest valuations, potentially offering a comparative hedge for investors seeking stability.
Market Context and Investor Takeaway
The lack of significant price swings for Doctorglasses Chain and its peers suggests that market sentiment is currently anchored by fundamentals rather than speculative momentum. The modest decline from the month‑end level, coupled with a 200‑day moving average that remains above the current price, signals that the stock remains in a defensive position. Investors may view this as an opportunity to reassess entry points, particularly as the company’s valuation metrics have not yet moved into extreme territory.
In summary, the Chinese equity market is experiencing a period of steadiness. Doctorglasses Chain, with its solid share volume and stable market capitalisation, continues to attract attention from long‑term investors who are monitoring its trajectory against a backdrop of peer companies that likewise exhibit low volatility.
